Abstract
As the pharmaceutical industry continues to re-strategise and focus on low-risk, relatively short-term gains for the sake of survival, we need to re-invigorate the early stages of drug discovery and rebalance efforts towards novel modes of action therapeutics and neglected genetic and tropical diseases. Academic drug discovery is one model which offers the promise of new approaches and an alternative organisational culture for drug discovery as it attempts to apply academic innovation and thought processes to the challenge of discovering drugs in addressing real unmet need.
| Original language | English |
|---|---|
| Pages (from-to) | 909-919 |
| Number of pages | 11 |
| Journal | Expert Opinion on Drug Discovery |
| Volume | 5 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- academia
- drug discovery
- neglected disease
- novel targets
- RESEARCH-AND-DEVELOPMENT
- OPEN INNOVATION
- INDUSTRY
Fingerprint
Dive into the research topics of 'Drug discovery in academia: the third way?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver